This week shops in the UK are introducing a new variety of broccoli, Beneforte, which reduces the risk of prostrate cancer in men.
It has long been known that glucoraphanin in broccoli lowers the rates of cancer. In 1983 a wild Italian broccoli variety was found to contain higher levels of glucoraphanin. The John Innes Centre in Norwich have bred this new variety, Beneforte, which contains two to three times the level of glucoraphanin than standard broccoli.
The Norfolk and Norwich University Hospital have worked with the Institute of Food Research to show that men who ate a broccoli-rich diet experienced changes in the activity of genes associated with tumour survival and growth.
Broccoli also lowers rates of heart disease and some other forms of cancer. It also boosts the body’s antioxidant enzyme levels.
Men who eat broccoli-rich diets have a reduced risk of aggressive prostate cancer – the most common non-skin cancer for males in western countries.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.